Customize your JAMA Network experience by selecting one or more topics from the list below.
This has been another extraordinary year for JAMA Pediatrics. We continue to pursue our mission to vet and disseminate the best science and perspectives related to child health. By the numbers presented in the Table,1-3 2019 was another extraordinary year for the journal. We received 2736 manuscripts, and our acceptance rate for research articles was 8%. Our impact factor inched up again to 12.0 and remains the highest of any pediatric journal in the world.
JAMA Pediatrics serves 2 sets of customers: readers and authors. For our authors, we aim to provide quick and thoughtful review of manuscripts. In most cases, this means manuscripts are only reviewed internally and not sent out for review. We make these decisions when we are confident that for a variety of reasons, the manuscript is not appropriate for our journal. For articles we do send out for peer review, the median turnaround time is 14 days. For our readers, we aim to bring science to the fore as quickly as possible. Our median acceptance to publication time is 102 days. But in the 21st century, science is disseminated in many other ways; we have a social media presence on Twitter and Facebook that continues to grow, millions of downloaded articles, and monthly podcasts4 that are of ever-increasing popularity. Finally, a relatively new measure of article impact is the Altmetric score, which uses a proprietary algorithm to quantify the quality and amount of attention an article receives from traditional and social media around the world. Our top 3 articles1-3 by Altmetric score from the past year are presented in the Table. Notably, the article with the highest Almetric score rekindled an old controversy related to the neurotoxic effects of fluoride. As noted in my Editor’s Note,5 publishing it was a deliberative decision. The ensuing media attention was not lost on policy makers or researchers, and I am hopeful that well-designed subsequent follow-up studies will further elucidate whether there is a true causal relationship here.
JAMA Pediatrics benefits immensely from being part of the JAMA Network. Submitted manuscripts can flow seamlessly from one journal to another where they might be a better fit. Published articles are frequently cross-linked with editorials or related content in other JAMA Network journals.
Our success is the result of the efforts of many, starting with the authors who entrust us with their work. We are honored to have it, and although we can only accept 8% of the research submissions we receive, we give each one careful and thoughtful consideration. Next, we have our editorial team of Julie Vo (who just joined our team) and Jennifer Matte, who process manuscripts, field emails and phone calls, and shepherd the entire process of getting things through the system. Next comes our crack editorial team, including Ron Keren, MD, MPH, as the journal’s Deputy Editor and a fantastic team of Associate Editors and Section Editors, including Aaron Carroll, MD, Alison Galbraith, MD, MPH, Megan Moreno, MD, MSEd, MPH, Deborah Palazzi, MD, MEd, and John Co, MD, MPH. Benjamin French, MD, provides crucial biostatistical review of all manuscripts prior to their acceptance. But most important, we rely on the thousands of outstanding peer reviewers,6 who selflessly donate their time and expertise. I give you my most heartfelt appreciation.
Corresponding Author: Dimitri A. Christakis, MD, MPH, Seattle Children’s Research Institute, Center for Child Health, Behavior, and Development, 2001 Eighth Ave, Ste 400, Seattle, WA 98121 (email@example.com).
Published Online: March 23, 2020. doi:10.1001/jamapediatrics.2020.0412
Conflict of Interest Disclosures: None reported.
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Christakis DA. JAMA Pediatrics—The Year in Review, 2019. JAMA Pediatr. 2020;174(5):415–416. doi:10.1001/jamapediatrics.2020.0412
Coronavirus Resource Center